Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
10 hedge funds and large institutions have $6.92M invested in Intellipharmaceuticals International Inc. in 2013 Q2 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BC
1
Broadfin Capital
New York
| $3.33M | +$3.61M | +196,078 | New |
|
|
TCM
2
Tekla Capital Management
Boston,
Massachusetts
| $2.81M | +$3.2M | +173,500 | New |
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $452K | +$491K | +26,650 | New |
|
|
FNYS
4
First New York Securities
New York
| $278K | +$302K | +16,374 | New |
|
5
Neuberger Berman Group
New York
| $49K | +$53.4K | +2,900 | New |
|
6
Bank of America
Charlotte,
North Carolina
| – | +$18 | +1 | New |
|
7
Bank of Montreal
Toronto,
Ontario, Canada
| – | +$18 | +1 | New |
|
|
LTFS
8
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | +$37 | +2 | New |
|
9
Wells Fargo
San Francisco,
California
| – | +$37 | +2 | New |
|
10
Nomura Holdings
Tokyo,
Japan
| – | +$184 | +10 | New |
|
IPCI Hedge Fund Activity: Q2 2013 in Review
10 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q2 2013, worth a combined $6.92M.
Buyers outnumbered sellers: 10 funds opened new IPCI positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
- 10 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $6.92M of Intellipharmaceuticals International Inc. stock for Q2 2013.
- 10 funds opened new Intellipharmaceuticals International Inc. positions in Q2 2013 and 0 closed out, a net change of +10 holders.
Based on aggregated 13F filings for Q2 2013.